Metro Boston Clinical Partners

Brighton, Massachusetts 02135

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Psoriasis Clinical Trial
This Study is Being Conducted to Evaluate the Safety, Tolerability, and Efficacy of KD025 Administered Orally for 16 Weeks to Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy.
Status: Enrolling, Phase II
Updated: 3/6/2017
mi
from
Brighton, MA
Click here to add this to my saved trials